Clinical study
Gynecomastia in a hospitalized male population

https://doi.org/10.1016/0002-9343(84)90353-XGet rights and content

Abstract

Two hundred fourteen hospitalized adult men, aged 27 to 92, were examined for the presence of palpable gynecomastia. The overall prevalence was 65 percent. Gynecomastia was bilateral in all but 11 subjects. The prevalence was greatest in the 50 to 69-year-old group (72 percent). It was lower in the 70- to 89-year-old (47 percent, p < 0.01) and the 30- to 49-year-old (54 percent, p < 0.05) groups. The prevalence of gynecomastia increased with body mass Index. More than 80 percent of those with a body mass Index of 25 kg/m2 or greater had gynecomastia. The diameter of breast tissue also increased with increasing body mass index (r = 0.52, p < 0.001). The decreased prevalence of gynecomastia after the seventh decade could be explained by the lower body mass index in this group. The youngest group did not have a lower body mass index; an independent age factor appeared to be present. Because of the high overall prevalence of gynecomastia, independent effects of diseases or medications could not be determined. It is concluded that palpable bilateral gynecomastia is present in most older men, is correlated with the amount of body fat, and does not require clinical evaluation unless symptomatic or of recent onset.

References (23)

  • KDG Edwards et al.

    The simple measurement of obesity

    Clin Sci

    (1962)
  • Cited by (164)

    • Management of Gynecomastia and Male Benign Diseases

      2022, Surgical Clinics of North America
    • Radiotherapy for prevention or management of gynecomastia recurrence: Future role for general gynecomastia patients in plastic surgery given current role in management of high-risk prostate cancer patients on anti-androgenic therapy

      2021, Journal of Plastic, Reconstructive and Aesthetic Surgery
      Citation Excerpt :

      Gynecomastia is the benign proliferation of glandular tissue affecting more than half of men to some degree throughout their lives.1–6

    • Gynecomastia

      2018, The Breast: Comprehensive Management of Benign and Malignant Diseases
    View all citing articles on Scopus

    This work was supported by research funding from the Veterans Administration.

    1

    From the Endocrine-Metabolic Section, Veterans Administration Medical Center, and the Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

    2

    Dr. Nuttall Is the recipient of a Veterans Adminstration Medical Investigatorship.

    View full text